Idivaysi isiza ukuhlola nokunquma inkambo yokwelashwa
Uma uthola ukuthi une-asthma, cishe uzocela ukuba uhambe ngenqubo ebizwa nge-spirometry. I-Spirometry yinto ejwayelekile yokuhlola okulinganisa kokubili ukuthi umoya omningi uhamba kanjani namaphaphu akho ngokushesha. Isivivinyo esinokwethenjelwa kakhulu kunemiphumela yokuphelelwa yisikhathi okuphezulu (PEF), okulinganisa kuphela ijubane lokuphela kwesikhathi.
Yize i-spirometry ingakwazi ukuhlola i-asthma yedwa, ingenye yamathuluzi asetshenziselwa ukuxilongwa.
Ibuye isekele ukuphathwa kwesifo sakho futhi ingasetshenziswa ukuqapha ukuqhubeka kwayo ngokuhamba kwesikhathi. Ukuhlolwa kwe-spirometry kwenziwa ehhovisi likadokotela futhi kungathatha cishe imizuzu engu-10 ukuya kwezingu-30, kuye ngokuhlola.
Indlela Yomoya Esetshenziswa Ngayo
I-Spirometry ivumela udokotela wakho ukuba alinganise izici eziningana zamaphaphu wakho ukuze anqume kokubili ubukhulu be-asthma yakho nokulawula izimpawu zakho. Izilinganiso ezintathu eziyinhloko yizi:
- Umthamo omkhulu - umoya omkhulu kunawo wonke uxoshwa emva kokuphefumula okujulile
- Inani lezinga lokugeleza lokuphefumula (PEFR) - ijubane elikhulu lokuphela kwesikhathi
- Ivolumu yokuphefumula okuphoqelelwe (FEV1) - kungakanani umoya oxoshwa ngomzuzwana owodwa
I-spirometer iqukethe umculi ohlangene nedivaysi ephethe ngesandla esilinganisa imiphumela njengoba uphefumula. Uma uhlolwa, uzonikezwa isiqeshana sekhasi ukuvimbela ukuphefumula emakhaleni. Ngemuva kokungenelela ngokujulile, uzocelwa ukuthi uphume ngamandla futhi isikhathi eside ngangokunokwenzeka.
I-Spirometry izovame ukuphinda iphindwe kathathu ukuze ubhale umphumela wakho omuhle kakhulu. Ungase ubuzwe futhi ukuthi uphinde uhlole ngemva kokusebenzisa i- bronchodilator encane efana ne-Albuterol.
Ukuhumusha Imiphumela
Enye yezindinganiso eziyinhloko udokotela wakho azobukeka yi-FEV1 yakho. Inani lincike kumaphesenti alokho okulindelwe kubantu abaningi.
Ngokusekelwe kulowo phesenti, udokotela wakho uzokwazi ukuhlukanisa izinga lokuvinjelwa kwamaphaphu elibangelwa i-asthma yakho. Amanani we-FEV1 aphulwa kanje:
- I-FEV1 engaphezu kwamaphesenti angu-80 okubikezelwe = Okujwayelekile
- I-FEV1 amaphesenti angu-60 kuya kuma-79 amaphesenti okubikezelwe = Ukuvinjelwa okuncane
- I-FEV1 amaphesenti angu-40 kuya ku-59 amaphesenti okubikezelwe = ukuvinjelwa okulinganiselwe
- I-FEV1 ngaphansi kwamaphesenti angu-40 okubikezelwe = ukuvinjelwa okukhulu
Uma udokotela wakho engaqiniseki ukuthi une-asthma, ukuthuthukiswa kwamaphesenti angu-12 noma ngaphezulu ngemuva kokusebenzisa i-inhaler yokulondoloza kuyanele ukuqinisekisa ukuthi ukuxilongwa.
I-Pros ne-Cons Home Spirometry
Kunezizathu eziningi zokuthi kungani ungafuna ukuthenga i-home spirometry unit. Abanye abantu basebenzisa njengendlela yokuziqapha isimo sabo. Abanye bathenga uma bengabanjwanga, bangaqinisekiswa, noma bangakwazi ukukhokhela izindleko zokuvakasha odokotela.
Ngokuthuthukiswa kwezobuchwepheshe, ikhaya le-spirometry liye lavunywa ngokwengeziwe ngumphakathi wezokwelapha. Ngaphandle kokuhamba kahle, idivayisi yasemakhaya ikuvumela ukuba uqaphele njalo izitayela ngezikhathi ezithile bese ubuyela kudokotela wakho. Lokhu kuphela kungasiza ukukwazisa ukwelashwa ngokwengeziwe kune-test eyodwa yehhovisi.
Ehlangothini le-flip, ngenkathi izindleko zehle kakhulu, ukuchithwa kwamadivayisi kungashintsha ngomkhiqizo, ngamanye amayunithi amanani aphansi ahlinzeka ngemiphumela enembile kakhulu.
Njengalokhu, i-spirometer yekhaya inganikeza okunye ukuthambekela kokusikisela kunokwenyama yangempela, okwenza kube yilapho ewusizo kakhulu esimweni somtholampilo. Abanye abahlinzeki baye baveza ukukhathazeka ukuthi i-home spirometers ingasetshenziselwa esikhundleni sokuvakashelwa odokotela njalo noma ukukhuthaza abantu ukuba balungise ukwelashwa ngaphandle kokufaka okuvela kudokotela wabo.
Uma unesithakazelo ku-spirometer yasekhaya, cela udokotela wakho izincomo noma ulethe idivayisi ehhovisi ukuze iqhathaniswe nalowo udokotela wakho asebenzisayo.
> Umthombo:
> McLaughlin, uM .; I-Rance, K .; futhi Stout, J. "Ukuqonda Spirometry in Care Primary." I-Journal of Asthma kanye Nezokwelapha Zokufundisa. 2013; 4 (6): 282-289.